About HRPHF
Partners and Links
HRPHF Connection
Online Giving
©  2009 All Rights Reserved  •  Hampton Roads Prostate Health Forum | Hampton, VA
Contact the Forum
Reach out to the Forum in a number of ways: 

Web Address: www.hrprostatehealth.org

Email: (general) info@hrprostatehealth.org 
(donations) donations@hrprostatehealth.org

Mailing Address: P.O. Box 6269, Norfolk, VA 23508

Office Number: (757) 

Fax Number: (757) 

Social Networking: 
HRPHF is a 501(c)(3) organization.
HOMERESEARCHAWARENESSEDUCATIONEARLY DETECTIONNAVIGATORTREATMENTSUPPORT

                Hampton Roads Prostate Health Forum Position Statement on
               PSA Testing for Men at Highest Risk of Having Prostate Cancer

The mission of the non-profit, 501 (c)(3) Hampton Roads Prostate Health Forum (HRPHF) is “to raise awareness and provide education regarding the prevention, diagnosis and treatment of prostate cancer through community and national outreach programs, synergistic communications and an established health alliance with local, regional and national medical organizations and providers.” In the following, several key members of the HRPHF Board of Directors and Medical and Community Advisory Boards offer their commentary on recent recommendations of the United States Preventive Services Task Force on the utility of Prostate Specific Antigen (PSA) testing in screening for Prostate Cancer.

“The Hampton Roads Prostate Health Forum is deeply disappointed that, despite high level and well recognized evidence for the use of Prostate Specific Antigen (PSA) testing as an aid to early prostate cancer detection, the recent United States Preventive Services Task Force has called for PSA testing to be abandoned completely,” said Charlie Hill, HRPHF president and a co-founder. 

“Adding uncertainty and confusion, the American Urological Association (AUA) and the
National Comprehensive Cancer Network (NCCN) support a role for PSA testing, but with somewhat conflicting recommendations. Their guidelines have endorsed the role of shared decision-making for men considering PSA testing,” according to Keith Gregory, vice president of the HRPHF and executive director of the Hampton University Proton Therapy Institute.

“Media reports on the PSA test controversy are confusing and preventing many men at
highest risk of having prostate cancer from having a discussion with doctors about early detection, even if they have a primary care physician (PCP). Those who don’t have doctors are simply lost and confused,” said Golden Bethune-Hill, a co-founder of the HRPHF and founder of the Community Free Clinic of Newport News (CFCNN). Bethune-Hill added, “Eighty per cent of the men seen at the CFCNN are men who don’t have a PCP, approximately 600 men.” 



                                                              Page 2